These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3469528)

  • 1. Conjugates of monoclonal antibody 791T/36 with methotrexate in cancer therapy.
    Baldwin RW; Embleton MJ; Garnett MC; Pimm MV
    NCI Monogr; 1987; (3):95-9. PubMed ID: 3469528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved synthesis of a methotrexate-albumin-791T/36 monoclonal antibody conjugate cytotoxic to human osteogenic sarcoma cell lines.
    Garnett MC; Baldwin RW
    Cancer Res; 1986 May; 46(5):2407-12. PubMed ID: 3457627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience in the preparation and experimental use of immunocytostatics.
    Embleton MJ; Pimm MV; Garnett MC; Rowland GF; Simmonds RG; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):108-12. PubMed ID: 6591915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.
    Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW
    Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates.
    Byers VS; Pimm MV; Scannon PJ; Pawluczyk I; Baldwin RW
    Cancer Res; 1987 Oct; 47(19):5042-6. PubMed ID: 3497715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of action of an antibody-targetted drug-carrier conjugate.
    Garnett MC; Embleton MJ; Jacobs E; Baldwin RW
    Anticancer Drug Des; 1985 Oct; 1(1):3-12. PubMed ID: 3879960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
    Affleck K; Embleton MJ
    Br J Cancer; 1992 Jun; 65(6):838-44. PubMed ID: 1616855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against osteosarcoma and colon cancer.
    Embleton MJ; Brown A; Gunn B; Byers VS; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):35-8. PubMed ID: 6591916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36.
    Pelham JM; Gray JD; Flannery GR; Pimm MV; Baldwin RW
    Cancer Immunol Immunother; 1983; 15(3):210-6. PubMed ID: 6577942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
    Embleton MJ; Garnett MC; Jacobs E; Baldwin RW
    Br J Cancer; 1984 May; 49(5):559-65. PubMed ID: 6586198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of methotrexate-monoclonal antibody conjugates for immunotherapy.
    Kanellos J; Pietersz GA; McKenzie IF
    J Natl Cancer Inst; 1985 Aug; 75(2):319-32. PubMed ID: 2991647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
    Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between monoclonal antibody-defined antigens on a human osteogenic sarcoma cell line (791T) and tumor-localizing properties of the anti-791T/36 antibody.
    Dawood F; Embleton MJ; Price MR; Pimm MV; Byers VS; Baldwin RW
    Braz J Med Biol Res; 1986; 19(2):257-69. PubMed ID: 3470084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies for radioimmunodetection of tumours and for targeting.
    Baldwin RW; Embleton MJ; Pimm MV
    Bull Cancer; 1983; 70(2):132-6. PubMed ID: 6575842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of anti-osteogenic sarcoma monoclonal antibody 791T/36 in a primary human osteogenic sarcoma and its subsequent xenograft in immunodeprived mice.
    Pimm MV; Perkins AC; Armitage NC; Baldwin RW
    Cancer Immunol Immunother; 1985; 19(1):18-21. PubMed ID: 3856475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer.
    Katzenwadel A; Schleer H; Gierschner D; Wetterauer U; Elsässer-Beile U
    Anticancer Res; 2000; 20(3A):1551-5. PubMed ID: 10928069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
    Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
    Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
    Price MR; Pimm MV; Baldwin RW
    Br J Cancer; 1982 Oct; 46(4):601-10. PubMed ID: 6958308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
    Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
    Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.